CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders

Negative
AI Analysis

Summary

Kaos Capital, a significant shareholder of Capricor Therapeutics (CAPR), issued a call demanding an immediate shareholder meeting, board changes, and a capital-preservation plan.

Importance:5/10
Sentiment:
-0.70
activismshareholderboard changecapital preservation
Related Companies

Read the original article

Published by PR Newswire Biotech on August 21, 2026 11:45 AM

Read Original